| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |